BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21889209)

  • 1. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
    Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
    Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
    Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
    Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.
    Prasad RB; Hosking FJ; Vijayakrishnan J; Papaemmanuil E; Koehler R; Greaves M; Sheridan E; Gast A; Kinsey SE; Lightfoot T; Roman E; Taylor M; Pritchard-Jones K; Stanulla M; Schrappe M; Bartram CR; Houlston RS; Kumar R; Hemminki K
    Blood; 2010 Mar; 115(9):1765-7. PubMed ID: 20042726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
    Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
    Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
    Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
    Bhandari P; Ahmad F; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
    Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
    Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
    [No Abstract]   [Full Text] [Related]  

  • 10. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
    Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
    Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
    Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
    Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
    Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
    Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
    Vijayakrishnan J; Sherborne AL; Sawangpanich R; Hongeng S; Houlston RS; Pakakasama S
    Leuk Lymphoma; 2010 Oct; 51(10):1870-4. PubMed ID: 20919861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea.
    Han S; Lee KM; Park SK; Lee JE; Ahn HS; Shin HY; Kang HJ; Koo HH; Seo JJ; Choi JE; Ahn YO; Kang D
    Leuk Res; 2010 Oct; 34(10):1271-4. PubMed ID: 20189245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.
    Burmeister T; Bartels G; Gröger D; Trautmann H; Schwartz S; Lenz K; Tietze-Bürger C; Viardot A; Wäsch R; Horst HA; Reinhardt R; Gökbuget N; Hoelzer D; Kneba M; Brüggemann M
    Haematologica; 2014 Feb; 99(2):e23-5. PubMed ID: 24497567
    [No Abstract]   [Full Text] [Related]  

  • 19. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
    Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
    Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
    [No Abstract]   [Full Text] [Related]  

  • 20. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.